Torrent Pharmaceuticals has successfully raised ₹12,500 crore via debentures, a strategic move to finance its takeover of JB Chemicals & Pharmaceuticals. By issuing commercial papers and non-convertible debentures with varying maturities, Torrent attracted investments from mutual funds, insurance firms, and pension funds. This financing decision underscores Torrent’s ambition to enhance its market presence and broaden its therapeutic offerings.
Q3 earnings, Fed rate decision, Budget to steer Dalal Street this week
Stock market is gearing up for an eventful week ahead where key triggers such as quarterly earnings from corporates, the US Fed interest rate decision